Electrochemical Synthesis of the In Human S-oxide Metabolites of Phenothiazine-Containing Antipsychotic Medications

Ridho Asra,Aigul Erbosynovna Malmakova,Alan M. Jones
DOI: https://doi.org/10.3390/molecules29133038
IF: 4.6
2024-06-27
Molecules
Abstract:The tractable preparation of Phase I drug metabolites is a critical step to understand the first-pass behaviour of novel chemical entities (NCEs) in drug discovery. In this study, we have developed a structure–electroactivity relationship (SeAR)-informed electrochemical reaction of the parent 2-chlorophenothiazine and the antipsychotic medication, chlorpromazine. With the ability to dial-in under current controlled conditions, the formation of S-oxide and novel S,S-dioxide metabolites has been achieved for the first time on a multi-milligram scale using a direct batch electrode platform. A potential rationale for the electrochemical formation of these metabolites in situ is proposed using molecular docking to a cytochrome P450 enzyme.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the synthesis of human S-oxidized metabolites of phenothiazine antipsychotic drugs through electrochemical methods. Specifically, the researchers developed an electrochemical reaction based on the structure-electroactivity relationship (SeAR) for the synthesis of S-oxidized and S,S-dioxidized metabolites of 2-chlorophenothiazine and chlorpromazine. This work aims to overcome the limitations of traditional chemical oxidation methods, such as complex design, operational difficulty, and the need for high-cost equipment, thereby providing a greener and more efficient synthesis method. The main objectives of the study include: 1. **Exploring and optimizing electrochemical conditions**: Investigate the electrochemical behavior of 2-chlorophenothiazine and chlorpromazine through cyclic voltammetry (CV) to determine the optimal current and voltage conditions for achieving efficient and selective S-oxidation reactions. 2. **Synthesis and characterization of metabolites**: Conduct electrochemical synthesis under optimized conditions, isolate and characterize the resulting S-oxidized and S,S-dioxidized metabolites, and verify their structure and purity. 3. **Understanding the metabolic mechanism**: Explore the binding modes of these metabolites in cytochrome P450 enzymes through molecular docking experiments to explain the formation mechanism of S-oxidized metabolites during electrochemical synthesis. In summary, this study aims to provide a new, environmentally friendly electrochemical synthesis method for drug metabolism research, to better understand and predict the metabolic behavior of new chemical entities (NCEs) in the human body.